Julia B Lewis

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi request reprint Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group
    J B Lewis
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232 2372, USA
    Am J Kidney Dis 34:809-17. 1999
  2. ncbi request reprint Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group
    J Lewis
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA
    Am J Kidney Dis 36:767-74. 2000
  3. ncbi request reprint In memory of a legendary athlete: measured success in diabetic nephropathy
    J Lewis
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA
    Semin Nephrol 21:124-32. 2001
  4. ncbi request reprint Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate
    J Lewis
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA
    Am J Kidney Dis 38:744-53. 2001
  5. ncbi request reprint Microalbuminuria as a target to improve cardiovascular and renal outcomes
    Seema Basi
    Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232 2372, USA
    Am J Kidney Dis 47:927-46. 2006
  6. ncbi request reprint Microalbuminuria as a target to improve cardiovascular and renal outcomes in diabetic patients
    Seema Basi
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Curr Diab Rep 7:439-42. 2007
  7. doi request reprint Blood pressure control in chronic kidney disease: is less really more?
    Julia B Lewis
    Division of Nephrology and Hypertension, Department of Medicine, S 2332 Medical Center North, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 2372, USA
    J Am Soc Nephrol 21:1086-92. 2010
  8. doi request reprint Nonproteinuric diabetic nephropathy: when diabetics don't read the textbook
    Jamie P Dwyer
    Division of Nephrology and Hypertension, and Nephrology Clinical Trials Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Med Clin North Am 97:53-8. 2013
  9. pmc CRP polymorphisms and progression of chronic kidney disease in African Americans
    Adriana M Hung
    Vanderbilt University Medical Center, 1161 21st Avenue South and Garland, Division of Nephrology, S 3223 MCN, Nashville, TN 37232 2372, USA
    Clin J Am Soc Nephrol 5:24-33. 2010
  10. ncbi request reprint Hypertension management: special considerations in chronic kidney disease patients
    James P Smith
    Division of Nephrology, Vanderbilt University Medical Center, S 3223 MCN, Nashville, TN 37232 2372, USA
    Curr Hypertens Rep 6:462-8. 2004

Detail Information

Publications26

  1. ncbi request reprint Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group
    J B Lewis
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232 2372, USA
    Am J Kidney Dis 34:809-17. 1999
    ..With the combination of ACE inhibition and intensive blood pressure control, many patients can achieve regression or apparent remission of clinical evidence of diabetic nephropathy...
  2. ncbi request reprint Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group
    J Lewis
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA
    Am J Kidney Dis 36:767-74. 2000
    ..6 versus 23.9 mm Hg; P < 0.001). This well-characterized population with oliguric acute renal failure had an overall high morbidity and mortality...
  3. ncbi request reprint In memory of a legendary athlete: measured success in diabetic nephropathy
    J Lewis
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA
    Semin Nephrol 21:124-32. 2001
    ..Multiple treatment modalities for patients once they reach end-stage renal disease are also available and great strides have been improving outcomes in these areas as well...
  4. ncbi request reprint Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate
    J Lewis
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA
    Am J Kidney Dis 38:744-53. 2001
    ..Formulas using demographic data and readily measured serum values estimate (125)I-iothalamate GFR...
  5. ncbi request reprint Microalbuminuria as a target to improve cardiovascular and renal outcomes
    Seema Basi
    Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232 2372, USA
    Am J Kidney Dis 47:927-46. 2006
    ..These data suggest that urinary albumin should be measured routinely and treated to afford cardiovascular and renoprotection...
  6. ncbi request reprint Microalbuminuria as a target to improve cardiovascular and renal outcomes in diabetic patients
    Seema Basi
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Curr Diab Rep 7:439-42. 2007
    ..There is also evidence that reducing the level of albuminuria improves these outcomes. This review focuses on the most recent advances in this area and reviews literature over the past year on this topic...
  7. doi request reprint Blood pressure control in chronic kidney disease: is less really more?
    Julia B Lewis
    Division of Nephrology and Hypertension, Department of Medicine, S 2332 Medical Center North, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 2372, USA
    J Am Soc Nephrol 21:1086-92. 2010
    ..A variety of observations suggest potential adverse events associate with achieving too low a BP in patients with chronic kidney disease, and ongoing randomized trials will have to establish the benefits or risks of meeting this goal...
  8. doi request reprint Nonproteinuric diabetic nephropathy: when diabetics don't read the textbook
    Jamie P Dwyer
    Division of Nephrology and Hypertension, and Nephrology Clinical Trials Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Med Clin North Am 97:53-8. 2013
    ..A well-designed biopsy study and a series of intervention trials are needed to fully understand this entity...
  9. pmc CRP polymorphisms and progression of chronic kidney disease in African Americans
    Adriana M Hung
    Vanderbilt University Medical Center, 1161 21st Avenue South and Garland, Division of Nephrology, S 3223 MCN, Nashville, TN 37232 2372, USA
    Clin J Am Soc Nephrol 5:24-33. 2010
    ..It is unknown if CRP polymorphisms are associated with CKD progression or modify the effectiveness of anti-hypertensive therapy in delaying CKD progression...
  10. ncbi request reprint Hypertension management: special considerations in chronic kidney disease patients
    James P Smith
    Division of Nephrology, Vanderbilt University Medical Center, S 3223 MCN, Nashville, TN 37232 2372, USA
    Curr Hypertens Rep 6:462-8. 2004
    ..Hopefully, with increased recognition of the unique aspects of treating hypertension in this population, end-stage renal disease and cardiovascular morbidity and mortality will be delayed or avoided in the millions of patients with CKD...
  11. pmc A framework for evaluating the appropriateness of clinical decision support alerts and responses
    Allison B McCoy
    Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee 77030, USA
    J Am Med Inform Assoc 19:346-52. 2012
    ..The authors present a comprehensive framework for evaluating the clinical appropriateness of synchronous, interruptive medication safety alerts...
  12. pmc Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations
    Lesley A Stevens
    Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 54:33-42. 2009
    ....
  13. ncbi request reprint Evaluation of renal artery stenosis in dialysis patients
    Jamie P Dwyer
    Division of Nephrology Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Semin Dial 22:519-23. 2009
    ..The risks of intervention must be weighed against the potential for renal recovery, even when predictors of success are not known with certainty...
  14. doi request reprint Optimizing blood pressure control in patients with nondiabetic glomerular disease
    Kausik Umanath
    Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN and Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN
    Adv Chronic Kidney Dis 21:200-4. 2014
    ..Renin-angiotensin system inhibitors should be used as the cornerstone of therapy for all patients with glomerular disease and CKD. ..
  15. doi request reprint Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial
    Jamie P Dwyer
    Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Am J Kidney Dis 61:759-66. 2013
    ..Most dialysis patients require phosphate binders to control hyperphosphatemia. Ferric citrate has been tested in phase 2 trials as a phosphate binder. This trial was designed as a dose-response and efficacy trial...
  16. ncbi request reprint Use of calcium antagonists in renal patients: therapeutic benefit or medical malpractice?
    Douglas A Nigbor
    Division of Nephrology, Vanderbilt University Medical Center, S 3223 MCN, Nashville, TN 37232 2372, USA
    Curr Hypertens Rep 5:430-6. 2003
    ..However, there is no conclusive evidence that calcium channel blockers are injurious to the kidney, and they may be particularly beneficial in post-renal transplant patients...
  17. pmc A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report
    Allison B McCoy
    Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA
    Am J Kidney Dis 56:832-41. 2010
    ..Frequently, prescribers fail to account for changing kidney function when prescribing medications. We evaluated the use of a computerized provider order entry intervention to improve medication management during acute kidney injury...
  18. ncbi request reprint Treatment of diabetic nephropathy with angiotensin II receptor antagonist
    Edmund J Lewis
    Rush Presbyterian St Luke s Medical Center, 1426 W Washington Blvd, Chicago, IL 60607, USA
    Clin Exp Nephrol 7:1-8. 2003
    ..Patients with type 2 diabetes and either early or late diabetic nephropathy should be treated with the angiotensin II receptor blocker irbesartan...
  19. doi request reprint Aliskiren combined with losartan in type 2 diabetes and nephropathy
    Hans Henrik Parving
    Department of Medical Endocrinology, Rigshospitalet, Copenhagen, Denmark
    N Engl J Med 358:2433-46. 2008
    ....
  20. ncbi request reprint Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy
    Tomas Berl
    University of Colorado Medical School, Denver, Colorado, USA
    Ann Intern Med 138:542-9. 2003
    ..The primary outcomes of the Irbesartan Diabetic Nephropathy Trial were doubling of serum creatinine levels, end-stage renal disease, and death from any cause...
  21. ncbi request reprint Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial
    Tomas Berl
    University of Colorado Health Sciences Center, 4200 East 9th Avenue, C 281, Denver, CO 80262, USA
    J Am Soc Nephrol 16:2170-9. 2005
    ..It is concluded that achieved SBP approaching 120 mmHg and diastolic BP of 85 mmHg are associated with the best protection against CV events in these patients. BP < or =120/85 may be associated with an increase in CV events...
  22. ncbi request reprint ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?
    Edmund J Lewis
    Rush University Medical Center, Chicago, Illinois, USA
    J Am Soc Nephrol 15:1358-60. 2004
  23. ncbi request reprint Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy
    David Aguilar
    Division of Cardiology, University of Texas Health Science Center, Houston, 77030, USA
    Am J Cardiol 94:337-9. 2004
    ..During a mean follow-up of 2.5 years, 14 of 99 first nonfatal MIs in this group were clinically unrecognized, accounting for 14% of all first nonfatal MIs...
  24. ncbi request reprint Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy
    Robert C Atkins
    Department of Nephrology, Monash Medical Centre, Victoria, Australia
    Am J Kidney Dis 45:281-7. 2005
    ....
  25. pmc Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans
    Lawrence J Appel
    Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Institutions, Johns Hopkins University, Baltimore, MD 21205 2223, USA
    Arch Intern Med 168:832-9. 2008
    ..A low blood pressure (BP) goal (BP, <130/80 mm Hg) is also recommended. The objective of this study was to determine the long-term effects of currently recommended BP therapy in 1094 African Americans with hypertensive CKD...
  26. ncbi request reprint Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?
    Seema Basi
    University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
    Diabetes Care 31:S194-201. 2008